Edward White
Stock Analyst at HC Wainwright & Co.
(1.74)
# 3,234
Out of 4,910 analysts
358
Total ratings
27.68%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $8.11 | +306.91% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $6.23 | +172.87% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $7.80 | +92.31% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $2.61 | +129.89% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.82 | +779.12% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.93 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $7.21 | +1,009.57% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.33 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $2.58 | +675.19% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.95 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.38 | +373.37% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.77 | +269.28% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.84 | +847.08% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.59 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.75 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $37.37 | +47.18% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $10.31 | +394.67% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.47 | +101.73% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $3.89 | +1,339.59% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $11.18 | +177.28% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.99 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.36 | +7,598.65% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $22.03 | +36.18% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.24 | +867.74% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $8.11
Upside: +306.91%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $6.23
Upside: +172.87%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $7.80
Upside: +92.31%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $2.61
Upside: +129.89%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.82
Upside: +779.12%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.93
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $7.21
Upside: +1,009.57%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.33
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $2.58
Upside: +675.19%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.95
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.38
Upside: +373.37%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.77
Upside: +269.28%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.84
Upside: +847.08%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $6.59
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.75
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $37.37
Upside: +47.18%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $10.31
Upside: +394.67%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $3.47
Upside: +101.73%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $3.89
Upside: +1,339.59%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $11.18
Upside: +177.28%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.99
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.36
Upside: +7,598.65%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $22.03
Upside: +36.18%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.24
Upside: +867.74%